Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease

Autor:	Aglitti, A., Caruso, R., Calvanese, G., Di Siervi, P., Tripodi, M.F., Masarone, M., Persico, M.
Zdroj:	In Digestive and Liver Disease February 2019 51 Supplement 1:e66-e66
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect